$22.74
3.81% yesterday
Nasdaq, Aug 11, 10:16 pm CET
ISIN
US86881A1007
Symbol
SGRY

Surgery Partners, Inc. Stock price

$22.74
+0.70 3.18% 1M
-3.01 11.69% 6M
+1.57 7.42% YTD
-6.36 21.86% 1Y
-14.43 38.82% 3Y
+2.47 12.19% 5Y
+4.63 25.57% 10Y
+4.63 25.57% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
-0.90 3.81%

Key metrics

Basic
Market capitalization
$2.9b
Enterprise Value
$6.2b
Net debt
$3.3b
Cash
$250.1m
Shares outstanding
128.2m
Valuation (TTM | estimate)
P/E
negative | 26.3
P/S
0.9 | 0.9
EV/Sales
1.9 | 1.8
EV/FCF
35.6
P/B
1.7
Financial Health
Equity Ratio
22.7%
Return on Equity
-9.4%
ROCE
6.6%
ROIC
0.2%
Debt/Equity
2.0
Financials (TTM | estimate)
Revenue
$3.2b | $3.4b
EBITDA
$644.9m | $571.6m
EBIT
$484.2m | $460.5m
Net Income
$-180.4m | $115.1m
Free Cash Flow
$175.3m
Growth (TTM | estimate)
Revenue
12.1% | 10.6%
EBITDA
11.8% | -8.8%
EBIT
8.0% | -2.9%
Net Income
-433.7% | 168.5%
Free Cash Flow
-14.1%
Margin (TTM | estimate)
Gross
26.5%
EBITDA
19.9% | 16.6%
EBIT
15.0%
Net
-5.6% | 3.3%
Free Cash Flow
5.4%
More
EPS
$-1.4
FCF per Share
$1.4
Short interest
19.6%
Employees
15k
Rev per Employee
$210.0k
Show more

Is Surgery Partners, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Surgery Partners, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Surgery Partners, Inc. forecast:

15x Buy
79%
4x Hold
21%

Analyst Opinions

19 Analysts have issued a Surgery Partners, Inc. forecast:

Buy
79%
Hold
21%

Financial data from Surgery Partners, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
3,237 3,237
12% 12%
100%
- Direct Costs 2,379 2,379
13% 13%
73%
858 858
10% 10%
27%
- Selling and Administrative Expenses 227 227
5% 5%
7%
- Research and Development Expense - -
-
-
645 645
12% 12%
20%
- Depreciation and Amortization 161 161
25% 25%
5%
EBIT (Operating Income) EBIT 484 484
8% 8%
15%
Net Profit -180 -180
434% 434%
-6%

In millions USD.

Don't miss a Thing! We will send you all news about Surgery Partners, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Surgery Partners, Inc. Stock News

Positive
The Motley Fool
6 days ago
Surgery Partners (SGRY -0.34%), a leading operator of ambulatory surgical facilities, announced its results for the second quarter on August 5, 2025. The company reported GAAP revenue of $826.2 million, surpassing analyst GAAP estimates of $818.4 million, while Non-GAAP earnings per share (EPS) came in at $0.17, slightly missing the $0.18 consensus (non-GAAP).
Neutral
Seeking Alpha
7 days ago
Surgery Partners, Inc. (NASDAQ:SGRY ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants David T. Doherty - Executive VP & CFO J.
Neutral
GlobeNewsWire
7 days ago
BRENTWOOD, Tenn., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced results for the second quarter ended June 30, 2025.
More Surgery Partners, Inc. News

Company Profile

Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services. The Surgical Facility Services segment consists of the operation of ambulatory surgery centers and surgical hospitals, including anesthesia services of the company. The Ancillary Services segment operates a diagnostic laboratory and multi-specialty physician practices. The Optical Services segment involves an optical laboratory and an optical products group purchasing organization. The company was founded in 2004 and is headquartered in Brentwood, TN.

Head office United States
CEO J. Evans
Employees 15,000
Founded 2004
Website surgerypartners.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today